Tricentis Acquires Tx3

The life sciences industry is undergoing major change, driven by increasing competitive pressures, digital transformation initiatives, and the need for more streamlined, cost-efficient processes. While life sciences companies seek to reduce the time it takes to bring new products to market, the FDA and other regulatory agencies across the globe help to ensure that the new products are rigorously tested for safety and efficacy.

A comprehensive validation program is a necessity in the life sciences industry to ensure regulatory compliance, and to help companies maintain consistent quality across the software development lifecycle. Now, the complexity of this task is greatly increased as more life science companies adopt agile and DevOps methodologies.

By adding Tx3’s Vera solution for digital validation to the Tricentis portfolio, customers now have access to a computer systems validation approach that is resilient and convenient enough to be practical in the context of constant change. Together, Tricentis and Tx3 will provide a comprehensive solution that improves the validation process so customers can both meet stringent regulatory requirements and achieve their digital transformation goals.